Xylazine toxicity: Difference between revisions

(Created page with "==Background== *analogue of clonidine and agonist at alpha 2 adrenergic receptor *used for sedation, anesthesia, muscle relaxation and analgesia in animals *used as drug of ab...")
 
No edit summary
Line 1: Line 1:
==Background==
==Background==
*analogue of clonidine and agonist at alpha 2 adrenergic receptor
*Analogue of [[clonidine]] and agonist at [[alpha-2 agonists|alpha 2 adrenergic receptor]]
*used for sedation, anesthesia, muscle relaxation and analgesia in animals
*Veterinary sedative, anesthetic, analgesic, and muscle relaxant
*used as drug of abuse, usually drug adulterant
*Human drug of abuse, usually as drug adulterant


==Clinical Features==
==Clinical Features==
*bradycardia
*[[Bradycardia]]
*respiratory depression
*[[Respiratory depression]]
*hypotension
*[[Hypotension]]


==Differential Diagnosis==
==Differential Diagnosis==
*other ingestions of sedative hypnotic agents
*See [[Bradycardia]], [[Hypotension]]
{{Sedatve/hypnotic toxicity types}}


==Evaluation==
==Evaluation==
 
*Evaluate for alternate etiologies
*Clinical diagnosis


==Management==
==Management==
*maintain respiratory function and blood pressure, atropine for bradycardia  
*Supportive: address airway/respiratory drive/blood pressure, [[atropine]] for bradycardia  


==Disposition==
==Disposition==
*admit for further monitoring
*Admit if not back to baseline


==See Also==
==See Also==
Line 30: Line 32:
https://www.ncbi.nlm.nih.gov/pubmed/24769343
https://www.ncbi.nlm.nih.gov/pubmed/24769343
<references/>
<references/>
[[Category:Toxicology]]

Revision as of 19:46, 21 August 2019

Background

Clinical Features

Differential Diagnosis

Sedative/hypnotic toxicity

Evaluation

  • Evaluate for alternate etiologies
  • Clinical diagnosis

Management

  • Supportive: address airway/respiratory drive/blood pressure, atropine for bradycardia

Disposition

  • Admit if not back to baseline

See Also

External Links

References

https://www.ncbi.nlm.nih.gov/pubmed/24769343